PHOENIX BIOTECH SPONSOR, LLC - 05 Oct 2021 Form 3 Insider Report for PHOENIX BIOTECH ACQUISITION CORP. (CERO)

Role
10%+ Owner
Signature
/s/ Chris Ehrlich, Manager
Issuer symbol
CERO
Transactions as of
05 Oct 2021
Net transactions value
$0
Form type
3
Filing time
05 Oct 2021, 18:56:43 UTC
Next filing
12 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PBAX Class A common stock 663,263 05 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PBAX Class B common stock 05 Oct 2021 Class A common stock 4,679,125 Direct F2, F3
holding PBAX Warrants 05 Oct 2021 Class A common stock 331,632 $11.50 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares underlie 663,263 units of the issuer that the reporting person irrevocably committed to purchase.
F2 The Class B shares will automatically convert into Class A shares at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.
F3 The shares of Class B common stock include up to 592,875 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option.
F4 The warrants will become exercisable at the later of 30 days after the consummation of the issuer's initial business combination or 12 months from the completion of the issuer's initial public offering.
F5 The warrants will expire five years after the consummation of the issuer's initial business combination or earlier upon redemption of all of the issuer's outstanding Class A common shares or the issuer's liquidation.
F6 These warrants underlie 663,263 units of the issuer that this entity irrevocably committed to purchase.